Jane Street
CCCC icon

Jane Street’s C4 Therapeutics CCCC Stock Holding History

Jane Street’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,100
Closed -$34.5K – 11661
2026
Q1 		$34.5K Buy
+13,100
New +$30.8K ﹤0.01% 11080
2024
Q1 		– Sell
-54,700
Closed -$309K – 9247
2023
Q4 		$309K Buy
+54,700
New +$125K ﹤0.01% 7556

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street's CCCC Position: Q2 2026 in Review

Jane Street reduced its C4 Therapeutics (CCCC) stake by 76% in Q2 2026, selling an estimated $3.23M and leaving 302,750 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #5799.

Jane Street first reported a position in CCCC in Q1 2021 and has held it in 15 quarters since. The position peaked at $3.28M in Q1 2026. 148 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Jane Street held 302,750 shares of C4 Therapeutics worth $1.41M as of Q2 2026.
  • Jane Street sold 944,146 C4 Therapeutics shares in Q2 2026, an estimated $3.23M.
  • C4 Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5799 holding.
  • Jane Street first reported a position in C4 Therapeutics in Q1 2021 and has held it in 15 quarters since.
  • Jane Street's C4 Therapeutics position peaked at $3.28M in Q1 2026.
  • 148 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.